Related Experiment Video
Updated: Jul 15, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Fetal growth and acute childhood leukemia: looking beyond birth weight
Elizabeth Milne1, Crystal L Laurvick, Eve Blair
1Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, Western Australia. lizm@ichr.uwa.edu.au
Insights
Accelerated fetal growth, not just high birth weight, increases the risk of childhood acute lymphoblastic leukemia (ALL). This finding suggests a potential role for insulin-like growth factor I in ALL development.
Area of Science:
- Pediatric Oncology
- Epidemiology
- Perinatal Health
Background:
- Childhood leukemia is a significant health concern.
- Understanding risk factors for leukemia, such as birth characteristics, is crucial for prevention and early detection.
Purpose of the Study:
- To investigate the association between birth weight, intrauterine growth, and the risk of childhood acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
Main Methods:
- Population-based cohort study in Western Australia (1980-2004).
- Followed 576,593 infants from birth to diagnosis, death, or end of follow-up (2005).
- Analyzed data using Cox regression.
Main Results:
- A positive association was found between the proportion of optimal birth weight and ALL risk, particularly in children under 5 years.
- Accelerated fetal growth, indicated by optimal birth weight proportion, was linked to a ~40% increase in ALL risk in younger children.
- Findings for AML were inconclusive due to small sample size.
Conclusions:
- Accelerated fetal growth, rather than high birth weight itself, may play a role in the etiology of ALL.
- Insulin-like growth factor I is a potential factor in the causal pathway of ALL.
- Further research is needed to confirm findings for AML.
Abstract:
The authors examined the relation between birth weight, intrauterine growth, and risk of childhood leukemia using population-based linked health data from Western Australia. A cohort of 576,593 infants born in 1980-2004 were followed from birth to diagnosis of acute lymphoblastic leukemia (ALL) (n = 243) or acute myeloid leukemia (AML) (n = 36) before their 15th birthday, death, or the end of follow-up (December 31, 2005). Data were analyzed using Cox regression. Risk of ALL was positively associated with the proportion of optimal birth weight--a measure of the appropriateness of fetal growth--particularly among children younger than 5 years; the hazard ratio for a 1-standard-deviation increase in proportion of optimal birth weight was 1.25 (95% confidence interval: 1.07, 1.47). Among children younger than 5 years not classified as having high birth weight (defined as >3,500 g, >3,800 g, and >4,000 g), a 1-unit increase in proportion of optimal birth weight was associated with an approximately 40% increase in ALL risk. This suggests that accelerated growth, rather than high birth weight per se, is involved in the etiology of ALL. These findings are consistent with a role for insulin-like growth factor I in the causal pathway. Findings for AML were inconclusive, probably because of small numbers.
Related Concept Videos
Nature and Nurture
Pharmacokinetics in Pediatric Patients: Drug Distribution
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
